Initiating warfarin therapy: 5 mg versus 10 mg

Area of Science:

• Pharmacology and Therapeutics
• Clinical Medicine

Background:

• Warfarin is a common oral anticoagulant used for venous thromboembolism.
• Initial dosing strategies for warfarin vary among clinicians.
• Optimal initial warfarin dosing remains a subject of research.

Purpose of the Study:

• To review literature on initial warfarin dosing (5 mg vs. 10 mg) for acute venous thromboembolism.
• To evaluate factors influencing warfarin maintenance dosage.

Main Methods:

• Literature search of MEDLINE (1966-2003) and bibliographies.
• Key search terms included warfarin, oral anticoagulation, and venous thromboembolism.
• Evaluation of studies on 5 mg vs. 10 mg initial warfarin doses.

Main Results:

• Previous studies suggested 5 mg and 10 mg initial doses were equally effective for venous thromboembolism.
• Recent evidence supports a 10 mg initial warfarin dose.
• Patient-specific factors influence warfarin maintenance dose, necessitating individualized treatment.

Conclusions:

• While recent evidence favors a 10 mg initial warfarin dose, patient factors are crucial.
• Clinicians must consider individual patient characteristics when determining initial warfarin dosage.
• Strict adherence to protocols is essential if using a 10 mg loading dose.